دورية أكاديمية

[Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results].

التفاصيل البيبلوغرافية
العنوان: [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results].
عنوان ترانسليتريتد: Erratum für: Das klinische Ergebnis eines Therapiewechsels von Ranibizumab und/oder Bevacizumab zu Aflibercept bei neovaskulärer altersabhängiger Makuladegeneration (AMD).
المؤلفون: Pfau M; Augenklinik, Universitätsklinikum Bonn., Fassnacht-Riederle HM; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Freiberg FJ; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Wons JB; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Wirth M; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Becker MD; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Michels S; Augenklinik, Stadtspital Triemli, Zürich, Schweiz.
المصدر: Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2016 Aug; Vol. 233 (8), pp. e3. Date of Electronic Publication: 2016 Sep 06.
نوع المنشور: Journal Article; Published Erratum
اللغة: German
بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 0014133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-3999 (Electronic) Linking ISSN: 00232165 NLM ISO Abbreviation: Klin Monbl Augenheilkd Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: Stuttgart : Thieme
Original Publication: Stuttgart.
التعليقات: Erratum for: Klin Monbl Augenheilkd. 2016 Aug;233(8):945-50. (PMID: 27123887)
تواريخ الأحداث: Date Created: 20160907 Latest Revision: 20191120
رمز التحديث: 20221213
DOI: 10.1055/s-0042-115798
PMID: 27599047
قاعدة البيانات: MEDLINE
الوصف
تدمد:1439-3999
DOI:10.1055/s-0042-115798